Similarly, the albumin‐adjusted sCa showed a dose‐dependent, sustained response that correlated with the Free PTH profile, with control of FECa despite mild hypercalcemia in the higher dose cohorts. The gene discussed is ALB; the disease is hypercalcemia disease.